Enlivex Therapeutics is trading 5.9% down today at $2.05 as the market continues to react to its recently announced $400 million private placement funded with crypto tokens.
- Shares are extending a steep selloff that began on July 28 following the surprise deal with a single unnamed institutional investor.
- Traders are still digesting significant dilution concerns and the highly unusual crypto structure of the financing.